Weight changes in postpartum women with remitted depression

Area of Science:

• Reproductive psychiatry
• Clinical pharmacology
• Postpartum health

Background:

• Postpartum depression is a significant concern for women with prior major depressive disorder.
• Antidepressants like nortriptyline and sertraline are used to prevent recurrent postpartum depression.
• Understanding the impact of these medications on postpartum physical recovery, specifically weight loss, is important.

Purpose of the Study:

• To compare postpartum weight loss in women treated with nortriptyline, sertraline, or placebo.
• To determine if antidepressant pharmacotherapy affects weight loss after childbirth.

Main Methods:

• Two clinical studies involving 60 women with a history of major depressive disorder were analyzed.
• Weight data were collected from 2 to 17 weeks postpartum.
• Weight at 11 and 17 weeks, and weight change from 2 to 17 weeks were the primary outcomes.

Main Results:

• No significant differences in mean weight at 17 weeks postpartum were observed between nortriptyline, sertraline, and placebo groups.
• While nortriptyline users showed slightly faster weight loss, the overall mean weight change was minimal (-1.8 lb).
• Postpartum weight retention was observed across all groups, irrespective of treatment.

Conclusions:

• Antidepressant pharmacotherapy did not compromise postpartum weight loss.
• Nondepressed women with a history of major depression experienced postpartum weight retention independent of antidepressant treatment.
• Further research may explore factors contributing to weight retention in this population.